Advisor Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $383K | Buy |
|
|||||
|
2022
Q1 | $437K | Buy |
|
|||||
|
2021
Q4 | $577K | Sell |
|
|||||
|
2021
Q3 | $638K | Sell |
|
|||||
|
2021
Q2 | $603K | Buy |
|
|||||
|
2021
Q1 | $457K | Buy |
|
|||||
|
2020
Q4 | $389K | Buy |
|
|||||
|
2020
Q3 | $343K | Sell |
|
|||||
|
2020
Q2 | $298K | Buy |
|
|||||
|
2020
Q1 | $212K | Sell |
|
|||||
|
2019
Q4 | $286K | Sell |
|
|||||
|
2019
Q3 | $248K | Buy |
|
|||||
|
2019
Q2 | $263K | Sell |
|
|||||
|
2019
Q1 | $284K | Sell |
|
|||||
|
2018
Q4 | $240K | Buy |
|
|||||
|
2018
Q3 | $276K | Sell |
|
|||||
|
2018
Q2 | $231K | Buy |
|
|||||
|
2018
Q1 | $203K | Sell |
|
|||||
|
2017
Q4 | $233K | Buy |
|
|||||
|
2017
Q3 | $232K | Buy |
|
|||||
|
2017
Q2 | $208K | Buy |
|